propafenone has been researched along with Myasthenia Gravis in 2 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lecky, BR | 1 |
| Weir, D | 1 |
| Chong, E | 1 |
| Fierro, B | 1 |
| Castiglione, MG | 1 |
| Salemi, G | 1 |
| Savettieri, G | 1 |
2 other studies available for propafenone and Myasthenia Gravis
| Article | Year |
|---|---|
Exacerbation of myasthenia by propafenone.
Topics: Aged; Coronary Disease; Heart Ventricles; Humans; Male; Myasthenia Gravis; Neurologic Examination; P | 1991 |
Myasthenia-like syndrome induced by cardiovascular agents. Report of a case.
Topics: Aged; Cardenolides; Coronary Disease; Drug Therapy, Combination; Humans; Male; Myasthenia Gravis; Ne | 1987 |